Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
05.08.23 | Sage Therapeutics, Inc.: FDA Approves ZURZUVAE (zuranolone), the First and Only Oral Treatment Approved for Women with Postpartum Depression, and Issues a Complete Response Letter for Major Depressive Disorder | 332 | Business Wire | CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics, Inc. (Nasdaq: SAGE) and Biogen Inc. (Nasdaq: BIIB) announced the U.S. Food and Drug Administration (FDA) approved ZURZUVAETM (zuranolone) 50 mg... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
EVOTEC | 2.559 |
NEL | 1.500 |
APPLE | 1.408 |
BYD | 1.314 |
BAYER | 1.310 |
SUPER MICRO COMPUTER | 1.228 |
DEUTSCHE BANK | 1.122 |
TUI | 1.092 |
NVIDIA | 1.073 |
PLUG POWER | 934 |
TESLA | 894 |
DAIMLER TRUCK | 885 |
MERCEDES-BENZ | 824 |
RWE | 794 |
RHEINMETALL | 782 |
AURUBIS | 743 |
RENK GROUP | 708 |
VOLKSWAGEN | 701 |
DEUTSCHE LUFTHANSA | 691 |
COMMERZBANK | 681 |
AMAZON | 653 |
SIEMENS ENERGY | 637 |
AIXTRON SE | 603 |
SIXT SE VZ | 592 |
BASF | 549 |